Microbot Medical Inc.

NASDAQ:MBOT

Medical - Instruments & Supplies

Healthcare
$0.98 -2.93%

-$0.06 today

Market cap
$65.73M
Beta
1.04
P/E (TTM)
-8.6
EPS (TTM)
-$0.21
52W Low $1.60High $4.67

Volume 0.87M

Average 1.60M

MBOT Cost of Revenue

Direct costs of producing the goods and services sold, such as materials, manufacturing, and service delivery.

Microbot Medical Inc.NASDAQ: MBOT

Cost of Revenue · Q1 FY2026 · quarter ended Mar 2026

Cost of revenue remains negative

Q1 FY2026 cost of revenue was $103K, compared with $0 a year earlier. Trailing-twelve-month cost of revenue was $115K.

Context

  • Cost of revenue increased in 1 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly cost of revenue holds near $103K or moves back toward the trailing-twelve-month quarterly average of $28.75K.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
$103K— QoQ
Last fiscal yearDec 2025
$0-100.0% YoY
LTMMar 2026
$115K+342.3% YoY
Cost of Revenue past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year-100.0%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Cost of Revenue history

USD · from the income statement

Latest · FY2025
0 USD
Year-over-year change
-100.0%

Cost of Revenue vs competitors

How MBOT compares with its peers on the latest reported figures

  • Peers report in different currencies, so cost of revenue is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +342.3% is the 3rd highest of 8, against a peer median of +29.5%.
  • Cost of revenue amounts to 109.5% of revenue for MBOT, versus a peer median of 70.5%.
MBOT Competitors
Cost of Revenue for MBOT and competitors
Company Period LTM YoY 3-year CAGR% of revenue
DCGODocGo Inc.LTM Mar 2026$212.57M USD-38.1%-7.9%70.5%
RCELAVITA Medical, Inc.LTM Mar 2026$13.48M USD+29.5%+28.4%18.6%
ZTEKZentek Ltd.LTM Mar 2026CA$4.36M CAD+545.4%+96.4%2622.4%
CLNNClene Inc.LTM Mar 2026$378K USD+410.8%+18.3%282.1%
VANIVivani Medical, Inc.LTM Mar 2026$130K USD+46.1%——
MBOTMicrobot Medical Inc.LTM Mar 2026$115K USD+342.3%—109.5%
CRDLCardiol Therapeutics Inc.LTM Mar 2026CA$52.73K CAD-33.2%——
CNTXContext Therapeutics Inc.LTM Mar 2026$40.17K USD———
OVIDOvid Therapeutics Inc.LTM Mar 2026$35K USD——0.5%
ORMPOramed Pharmaceuticals Inc.LTM Mar 2026$31K USD-98.5%——
Peer median (excluding MBOT) —+29.5%+23.3%70.5%

Competitors are the stored peer set for MBOT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue00000
Cost of Revenue00106K91K0
Gross Profit00(106K)(91K)0
Gross Margin—————
Research & Development6.15M7.74M5.72M6.63M6.28M
Selling, General & Admin5.41M5.58M4.13M5M8.25M
Operating Expenses11.36M13.28M9.75M11.53M14.74M
Depreciation & Amortization76K102K106K91K47K
EBITDA(11.24M)(13.34M)(10.63M)(11.35M)(13.1M)
EBITDA Margin—————
Operating Income(11.36M)(13.28M)(9.86M)(11.63M)(14.74M)
Operating Margin—————
Interest Income44K54K228K182K1.29M
Interest Expense00000
Other Income / Expenses44K113K(885K)182K1.6M
Income Before Tax(11.31M)(13.17M)(10.74M)(11.44M)(13.14M)
Pre-Tax Margin—————
Income Tax Expense00000
Net Income(11.31M)(13.17M)(10.74M)(11.44M)(13.14M)
Net Margin—————
EPS (Basic)(1.59)(1.81)(1.05)(0.73)(0.29)
EPS (Diluted)(1.59)(1.81)(1.05)(0.73)(0.29)
Weighted Avg Shares7.11M7.26M10.2M15.65M45.79M
Weighted Avg Shares (Diluted)7.11M7.26M10.2M15.65M45.79M

Microbot Medical Inc.

NASDAQ:MBOT

Intrinsic Alpha fair value

Locked

Current Price

$0.98

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.